(Q44443514)

3 December 2017

Comparison of line probe assay (LIPA) and sequence analysis for detection of HIV-1 drug resistance (English)

1 reference

3 December 2017

Puchhammer-Stöckl E

1

1 reference

3 December 2017

Schmied B

2

1 reference

3 December 2017

Mandl CW

3

1 reference

3 December 2017

Vetter N

4

1 reference

3 December 2017

Heinz FX

5

1 reference

3 December 2017

1 March 1999

1 reference

Journal of Medical Virology

3 December 2017

1 reference

3 December 2017

57

1 reference

3 December 2017

3

1 reference

3 December 2017

283-289

1 reference

Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects

3 December 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

HIV viral load markers in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199903%2957%3A3%3C283%3A%3AAID-JMV12%3E3.0.CO%3B2-2

10.1002/(SICI)1096-9071(199903)57:3<283::AID-JMV12>3.0.CO;2-2

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference